Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population

Journal of Sleep Research

Volumn 21, Issue 2, 2012, Pages 147-154

  Svensson, Malin ^a   Venge, Per ^a   Janson, Christer ^a   Lindberg, Eva ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Inflammation; Sleep apnea; Women

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LYSOZYME; OXYGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATIONAL STUDY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; OBESITY; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP DISORDERED BREATHING; SLEEP TIME; SMOKING; SNORING; WAIST CIRCUMFERENCE;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MIDDLE AGED; MURAMIDASE; PEROXIDASE; POLYSOMNOGRAPHY; QUESTIONNAIRES; SLEEP APNEA SYNDROMES; SNORING; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84858780803     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/j.1365-2869.2011.00946.x     Document Type: Article

References (40)

1. Andelid, K., Bake, B., Rak, S., Linden, A., Rosengren, A. and Ekberg-Jansson, A. Myeloperoxidase as a marker of increasing systemic inflammation in smokers without severe airway symptoms. Respir. Med., 2007, 101: 888-895.
2. Fletcher, E. C., Lesske, J., Behm, R., Miller, C. C., 3rd, Stauss, H. and Unger, T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J. Appl. Physiol., 1992, 72: 1978-1984.
3. Greenberg, H., Ye, X., Wilson, D., Htoo, A. K., Hendersen, T. and Liu, S. F. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem. Biophys. Res. Commun., 2006, 343: 591-596.
4. Grundy, S. M., Cleeman, J. I., Daniels, S. R. et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol. Rev., 2005, 13: 322-327.
5. Guilleminault, C., Kirisoglu, C. and Ohayon, M. M. C-reactive protein and sleep-disordered breathing. Sleep, 2004, 27: 1507-1511.
6. Hatipoglu, U. and Rubinstein, I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration, 2003, 70: 665-671.
7. Johns, M. W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 1991, 14: 540-545.
8. Kaptoge, S., Di Angelantonio, E., Lowe, G. et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet, 2010, 375: 132-140.
9. Krueger, J. M., Obal, F. J., Fang, J., Kubota, T. and Taishi, P. The role of cytokines in physiological sleep regulation. Ann. N Y Acad. Sci., 2001, 933: 211-221.
10. Lavie, L. Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurol. Clin., 2005, 23: 1059-1075.
11. Lavie, P., Herer, P., Peled, R. et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep, 1995, 18: 149-157.
12. Lesske, J., Fletcher, E. C., Bao, G. and Unger, T. Hypertension caused by chronic intermittent hypoxia - influence of chemoreceptors and sympathetic nervous system. J. Hypertens., 1997, 15: 1593-1603.
13. Li, J., Thorne, L. N., Punjabi, N. M. et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ. Res., 2005, 97: 698-706.
14. Lindberg, E., Janson, C., Gislason, T., Svardsudd, K., Hetta, J. and Boman, G. Snoring and hypertension: a 10 year follow-up. Eur. Respir. J., 1998, 11: 884-889.
15. Mocatta, T. J., Pilbrow, A. P., Cameron, V. A. et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J. Am. Coll. Cardiol., 2007, 49: 1993-2000.
16. Mohamed-Ali, V., Goodrick, S., Rawesh, A. et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab., 1997, 82: 4196-4200.
17. Muraki, I., Tanigawa, T., Yamagishi, K. et al. Nocturnal intermittent hypoxia and C reactive protein among middle-aged community residents: a cross-sectional survey. Thorax, 2010, 65: 523-527.
18. Nicholls, S. J. and Hazen, S. L. Myeloperoxidase and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol., 2005, 25: 1102-1111.
19. Peppard, P. E., Young, T., Palta, M. and Skatrud, J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med., 2000, 342: 1378-1384.
20. Punjabi, N. M. and Beamer, B. A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep, 2007, 30: 29-34.
21. Rechtschaffen, A. and Kales, A. A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages in Human Subjects. National Public Health Service, US Government Printing Office, Washington DC, 1968.
22. Ridker, P. M., Rifai, N., Stampfer, M. J. and Hennekens, C. H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 2000, 101: 1767-1772.
23. Roche, F., Gaspoz, J. M., Pichot, V. et al. Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly. Eur. Respir. J., 2009, 33: 797-803.
24. Ross, R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med., 1999, 340: 115-126.
25. Ryan, S., Taylor, C. T. and Mcnicholas, W. T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation, 2005, 112: 2660-2667.
26. Sahlin, C., Sandberg, O., Gustafson, Y. et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch. Intern. Med., 2008, 168: 297-301.
27. Sahlman, J., Miettinen, K., Peuhkurinen, K. et al. The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J. Sleep Res., 2010, 19: 341-348.
28. Seidell, J. C., Perusse, L., Despres, J. P. and Bouchard, C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am. J. Clin. Nutr., 2001, 74: 315-321.
29. Shamsuzzaman, A. S. M., Winnicki, M., Lanfranchi, P. et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation, 2002, 105: 2462-2464.
30. Sirpal, S. Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease. Clin. Sci., 2009, 116: 681-695.
31. Svensson, M., Franklin, K. A., Theorell-Haglow, J. and Lindberg, E. Daytime sleepiness relates to snoring independent of the apnea-hypopnea index in women from the general population. Chest, 2008, 134: 919-924.
32. Taheri, S., Austin, D., Lin, L., Nieto, F. J., Young, T. and Mignot, E. Correlates of serum C-reactive protein (CRP) - no association with sleep duration or sleep disordered breathing. Sleep, 2007, 30: 991-996.
33. Tamaki, S., Yamauchi, M., Fukuoka, A. et al. Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern. Med., 2009, 48: 1255-1262.
34. Valham, F., Mooe, T., Rabben, T., Stenlund, H., Wiklund, U. and Franklin, K. A. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation, 2008, 118: 955-960.
35. Venge, P., Hallgren, R., Stalenheim, G. and Olsson, I. Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis. Scand. J. Haematol., 1979, 22: 317-326.
36. Vgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Kales, A., Tyson, K. and Chrousos, G. P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab., 1997, 82: 1313-1316.
37. Visser, M., Bouter, L. M., Mcquillan, G. M., Wener, M. H. and Harris, T. B. Elevated C-reactive protein levels in overweight and obese adults. JAMA, 1999, 282: 2131-2135.
38. Yamauchi, M., Tamaki, S., Tomoda, K. et al. Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath, 2006, 10: 189-193.
39. Yokoe, T., Minoguchi, K., Matsuo, H. et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation, 2003, 107: 1129-1134.
40. Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S. and Badr, S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med., 1993, 328: 1230-1235.